ProgramsView all programs
From the news
- Chancellor Amma Addresses the Parliament of World’s Religions
- Amrita Students Qualify for the European Mars Rover Challenge
Publication Type : Journal Article
Publisher : Indian Journal of Dermatology
Source : Indian Journal of Dermatology, Volume 56, Number 3, p.306-308 (2011)
Keywords : add on therapy, adult, alanine aminotransferase, alanine aminotransferase blood level, anemia, article, aspartate aminotransferase, aspartate aminotransferase blood level, C reactive protein, case report, cyclosporin, cytophagic histiocytic panniculitis, dexamethasone, dipeptidyl carboxypeptidase, disease duration, ecchymosis, erythrocyte sedimentation rate, female, ferritin, ferritin blood level, fibrinogen, fibrinogen blood level, follow up, hemoglobin, hemoglobin blood level, human, human tissue, hypertransaminasemia, lactate dehydrogenase, lactate dehydrogenase blood level, leukopenia, liver function test, panniculitis, partial thromboplastin time, prednisolone, prothrombin time, skin biopsy, skin examination, skin necrosis, skin ulcer, subcutaneous tissue, thrombocytopenia
Campus : Kochi
School : School of Medicine
Department : Dermatology
Year : 2011
Abstract : Cytophagic histiocytic panniculitis (CHP) was first described in 1980 by Winkelmann as a chronic histiocytic disease of the subcutaneous adipose tissue, which is characterized clinically by tender erythematous nodules, recurrent high fever, malaise, jaundice, organomegaly, serosal effusions, pancytopenia, hepatic dysfunction, and coagulatory abnormalities. CHP may occur either isolated or as part of cutaneous manifestations of hemophagocytic syndrome. Here, we report two different presentations of CHP.
Cite this Research Publication : Ja Manoj, Kaliyadan, Fa, Unni, Mb, and Dharmaratnam, A. Da, “Cytophagic histiocytic panniculitis: Report of two cases”, Indian Journal of Dermatology, vol. 56, pp. 306-308, 2011.